From subthalamic local field potentials to the selection of chronic deep brain stimulation contacts in Parkinson's disease - A systematic review
- PMID: 40803531
- DOI: 10.1016/j.brs.2025.08.004
From subthalamic local field potentials to the selection of chronic deep brain stimulation contacts in Parkinson's disease - A systematic review
Abstract
Background: Programming deep brain stimulation (DBS) of the subthalamic nucleus for optimal symptom control in Parkinson's Disease (PD) requires time and trained personnel. Novel implantable neurostimulators allow local field potentials (LFP) recording, which could be used to identify the optimal (chronic) stimulation contact. However, literature is inconclusive on which LFP features and prediction techniques are most effective.
Objective: To evaluate the performance of different LFP-based physiomarkers for predicting the optimal (chronic) stimulation contacts.
Methods: A literature search was conducted across nine databases, resulting in 418 individual papers. Two independent reviewers screened the articles based on title, abstract, and full text. The quality of included studies was assessed using a modified Joanna Briggs Institute Critical Appraisal Checklist for Case Series. Results were categorised in four classes based on the predictive performance with respect to the a priori chance.
Results: Twenty-five studies were included. Single-feature beta-band predictions demonstrated positive performance scores in 94 % of the outcomes. Predictions based on single non-beta-frequency features yielded positive scores in only 25 % of the outcomes, with positive results mainly for high frequency oscillations. Multi-feature predictions (e.g. machine learning) achieved accuracy scores within the two highest performance classes more often than single beta-based predictions (100 % versus 39 %).
Conclusion: Predicting the optimal stimulation contact based on LFP recordings is feasible and can improve DBS programming efficiency in PD. Single beta-band predictions show more promising results than non-beta-frequency features alone, but are outperformed by multi-feature predictions. Future research should further explore multi-feature predictions for optimal contact identification.
Keywords: Clinical contact choice; Deep brain stimulation; Local field potentials; Parkinson's disease; Subthalamic nucleus.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MFC is an independent consultant for research and educational issues of Medtronic (all fees to institution), is an independent consultant for research by INBRAIN (all fees to institution), provides research support/contracted research for Boston Scientific (all fees to institution) and received speaking fees for: ECMT (CME activity), and Boston Scientific (all fees to institution). All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. No other authors have competing interests to declare.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Dominant twin peaks: a novel conjecture for the pathophysiologic basis of tremor frequency and fluctuation time in Parkinson's disease.Front Neurosci. 2025 Jun 18;19:1398834. doi: 10.3389/fnins.2025.1398834. eCollection 2025. Front Neurosci. 2025. PMID: 40606835 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources